Results 131 to 140 of about 15,404 (212)

Limited Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Appetite and Body Weight: Evidence From Clinical and Rodent Studies. [PDF]

J Korean Med Sci
Lee J, Park S, Kim E, Park JY, Rhee M, Hughes JW, Ko SH, Kwon O, Lee EY.   +8 more
europepmc   +1 more source

Comparison of the Continuous Glucose Monitoring Profiles of Four Glucose-Lowering Medications in the GRADE Randomized Trial. [PDF]

Diabetes Care
Bergenstal RM, Crandall JP, Rosin SP, Butera NM, Bantle A, Desouza C, Duran-Valdez E, Hall S, Herman WH, Johnson ML, Lagari V, Larkin ME, Phillips LS, Willis HJ, Krause-Steinrauf H, GRADE Research Group*.   +15 more
europepmc   +1 more source

Dapagliflozin-Based Therapies in Patients With Type 2 Diabetes Mellitus in an Outpatient Real-World Setting Across India: The DAPATURN Study. [PDF]

Cureus
Chawla R, T K S, Singh KP, Mehta A, Chattopadhyay M, Rakshit KM, Motiramani N, Philip R, Shinde AC, K SM, Revenkar S, Patel K.   +11 more
europepmc   +1 more source

Eco-friendly second-derivative synchronous fluorescence method for the determination of empagliflozin and sitagliptin in tablets and plasma samples. [PDF]

Sci Rep
Mohamad AAA, Almrasy AA, Abdelazim AH, Taha AS.   +3 more
europepmc   +1 more source

Triple oral therapy combining metformin, SGLT-2 and DPP-4 inhibitors versus dual therapy in type 2 diabetes mellitus: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Malik AF, Kashish F, Shivani F, Kumar S, Kumari V, Haseeb A, Mujtaba A, Raheem A, Ali SMS, Saleh U, Ahmad TKF.   +10 more
europepmc   +1 more source

Anti-diabetic medications to fight Parkinson's disease and dementia with Lewy bodies: a pilot study. [PDF]

Front Neurol
Chmiela T, Dulski J, Heckman MG, Fang ZJ, Wszolek ZK, Wilson JR.   +5 more
europepmc   +1 more source

Acute Pancreatitis in a Young Patient With Type 2 Diabetes Mellitus Taking Sitagliptin and the Combined Oral Contraceptive Pill. [PDF]

Cureus
Ruwanpathiranage T, Olorunfemi H, Sagi SV, Varughese S, Oyibo SO.   +4 more
europepmc   +1 more source

DPP-4 Inhibitors in Female Cancers: Opportunities for Drug Repurposing. [PDF]

Curr Issues Mol Biol
Muddather HF, Schelz Z, Zupkó I.
europepmc   +1 more source

Progressive loss of glycemic control during chronic DPP-4 inhibitor therapy despite preserved β-cell function: a case report suggesting acquired incretin resistance. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Prasad S, Ahuja A, Sharma S, Nagda J, Agrawal S, Parmar V, Vardhan H.   +6 more
europepmc   +1 more source

ILK-Dependent Modulation of DPP4 Prevents Progression of Calcific Aortic Valve Disease. [PDF]

Arterioscler Thromb Vasc Biol
Delgado-Marín M, Sánchez-Esteban S, Cook-Calvete A, Castro-Pinto M, López-Menendez J, Hernandez I, Zamorano JL, Zaragoza C, Saura M.   +8 more
europepmc   +1 more source